New challenges in perioperative management of pancreatic cancer - Wikidata - wikimedia - TriplyDB

New challenges in perioperative management of pancreatic cancer

New challenges in perioperative management of pancreatic cancer

http://www.wikidata.org/entity/Q28082422

about

Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients.Pathologic Major Response After FOLFIRINOX is Prognostic for Patients Secondary Resected for Borderline or Locally Advanced Pancreatic Adenocarcinoma: An AGEO-FRENCH, Prospective, Multicentric Cohort.How the radiologist can add value in the evaluation of the pre- and post-surgical pancreas.A Comparative Study of Clinical Intervention and Interventional Photothermal Therapy for Pancreatic Cancer.Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification.MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer.Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients.Bevacizumab and cetuximab with conventional chemotherapy reduced pancreatic tumor weight in mouse pancreatic cancer xenografts.Overexpression of FZD1 and CAIX are Associated with Invasion, Metastasis, and Poor-Prognosis of the Pancreatic Ductal Adenocarcinoma.CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma.LncRNA-PVT1 promotes pancreatic cancer cells proliferation and migration through acting as a molecular sponge to regulate miR-448.The application of a three-dimensional visualized seed planning and navigation system in 125I seed implantation for pancreatic cancer.miR-128 induces pancreas cancer cell apoptosis by targeting MDM4.

P2860

Q26766690-090ED0AA-16D8-4A8E-9943-49E7444E0EEA Q26767041-54633691-3BF1-4EB1-8E6D-20B5B9625017 Q26768261-C88BFDB3-881E-47A7-80CE-14C85B1BDAB6 Q33439342-F32E4991-106C-4215-BF33-B866C4111517 Q38566193-E58A832F-D624-4722-AA90-D2F1D1612577 Q38611312-12207747-ED9D-4DC4-9604-4352B756C532 Q38662058-23766121-269D-4B5F-98DC-7696137ACB52 Q38838295-83120F35-A653-4F3F-A5C4-ADEB4A0E4B6D Q40559757-6ECC949A-BEF2-42A9-8C4C-004EF3A8C5EA Q47101670-12282069-79D0-4F38-8598-4460702F5AA5 Q47317142-C07561FE-A3CA-43AF-93A8-B19878439A51 Q47786737-D2A296A0-0751-4E7F-A0F7-707B3506E535 Q48192104-E8AC6F3B-F29B-41D6-AB5D-95C3472E5300 Q48212048-01DDF24B-BF75-40BF-8436-C9718FA4C967 Q49457016-BF575E86-A106-4382-B31B-7CBC02FE3E70 Q54959414-0855E4B9-4A17-49F1-BBB3-637F8CD4B943

P2860

New challenges in perioperative management of pancreatic cancer

http://www.wikidata.org/entity/Q28082422

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

New challenges in perioperative management of pancreatic cancer

@ast

New challenges in perioperative management of pancreatic cancer

@en

New challenges in perioperative management of pancreatic cancer

@nl

type

label

New challenges in perioperative management of pancreatic cancer

@ast

New challenges in perioperative management of pancreatic cancer

@en

New challenges in perioperative management of pancreatic cancer

@nl

prefLabel

New challenges in perioperative management of pancreatic cancer

@ast

New challenges in perioperative management of pancreatic cancer

@en

New challenges in perioperative management of pancreatic cancer

@nl

P1433

Q28082422-BC23AB5D-2AB7-4686-BB7A-7280F6E3AE0D

P1476

Q28082422-666C2570-AE71-4BBD-A422-FBF5165A84BD

P2093

Q28082422-1B1A1C0B-6EB2-4BA2-80AE-5B7D9125B5DE

Q28082422-28E95C71-8BEE-4B53-8CAB-42756CA97F45

Q28082422-94CD47E2-0830-44EC-9C21-6F46B03376F1

Q28082422-961FF5E7-3F73-43DF-BE5A-8E29D6F6CE95

Q28082422-9F71EB09-4F41-4609-9ABF-0F833896F25B

Q28082422-A7053A29-1367-44A6-AEF4-CF208F8296D3

Q28082422-BBBC1B5A-6968-4253-A756-341C4253E50C

P2860

Q28082422-0F508BFD-D787-4F74-A84A-B646149D85BD

Q28082422-1790F93C-408A-4CD0-A4AC-4FD16C85E830

Q28082422-18C1BF26-3CE4-4844-B7A5-237D8D4FD7C3

Q28082422-194D6D2F-21EE-4338-AD92-EF2C3473A71E

Q28082422-1A4C7464-5148-4040-A6FD-5899D070085D

Q28082422-211D7FA2-BEE1-46B1-822E-6CA95362CBA1

Q28082422-214E6855-3B0E-4AB5-BA71-05644521EFCF

Q28082422-29FEC35E-21FD-4B9C-8614-D02B3CA88D2B

Q28082422-2C4FA8E9-1F10-4820-A50D-4191E2A45DD1

Q28082422-324D2A6A-07F3-4B94-83A7-C5BEEDC0B34E

P304

Q28082422-B6447F32-E608-44C3-BDA6-FF5B9B12ABDE

P31

Q28082422-E96A45E7-4D5C-4675-AE26-2ED646728F0E

P356

Q28082422-863B0711-D2E2-4F77-9C0D-1C40389A41AD

P407

Q28082422-E0600DBB-17E6-43F8-BD61-21392F3AC34D

P433

Q28082422-0C40A390-F8E2-410A-918D-85F2478D7076

P478

Q28082422-7FBC2338-DC48-4256-B0C1-FDB82123ABB9

P50

Q28082422-35EB6D16-53D5-42CE-BFCE-C21FF38BD759

Q28082422-A72C95D1-F802-443B-815C-A5401643CB90

P577

Q28082422-46B39691-CA7B-4AA3-9945-69409DD008EC

P5875

Q28082422-75987670-DE1A-47E8-9040-A98D40D514F6

P698

Q28082422-81DD839A-13B2-40CF-96BB-EC7F3E1C2FCF

P932

Q28082422-58FB0118-74B9-49EB-90A0-E6743238EBB7

P356

WJG.V21.I8.2281

P1433

World Journal of Gastroenterology

P1476

New challenges in perioperative management of pancreatic cancer

@en

P2093

Annabelle Calomme

http://www.w3.org/2001/XMLSchema#string

Jacques Deviere

http://www.w3.org/2001/XMLSchema#string

Jean Closset

http://www.w3.org/2001/XMLSchema#string

Jean-Luc Van Laethem

http://www.w3.org/2001/XMLSchema#string

Maria-Antonietta Bali

http://www.w3.org/2001/XMLSchema#string

Pieter Demetter

http://www.w3.org/2001/XMLSchema#string

Raphaël Maréchal

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.

Cancer statistics, 2012

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

Cancer statistics, 2009

Analysis of circulating tumor DNA to monitor metastatic breast cancer

EMT and dissemination precede pancreatic tumor formation

Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.

A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin.

P304

2281-2293

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V21.I8.2281

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Puleo

Jean-Baptiste Bachet

P577

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273148939

http://www.w3.org/2001/XMLSchema#string

P698

25741134

http://www.w3.org/2001/XMLSchema#string

P932

4342903

http://www.w3.org/2001/XMLSchema#string